Introducing the TRI Executive Team led by Professor Scott Bell, CEO of TRI. 



Chief Executive Officer 

Professor Bell is a leading clinician and researcher in Cystic Fibrosis (CF).  He recently co-led the development of a new global blueprint for the care of people with the fatal genetic disorder. His work will help the 3500 Australians with the incurable condition to live decades longer. Professor Bell has over 250 peer reviewed publications and has received grant support in excess of $22 million over the past 10 years.  He is a Senior Thoracic Physician at the Prince Charles Hospital and Editor-in Chief of the Journal of Cystic Fibrosis.  Prior to his appointment as TRI CEO, Professor Bell was the Executive Director of Research at Metro North Health and the head of QIMR Berghofer’s Lung Bacteria laboratory.


​Chair - CRF Committee 

David has had a long career in clinical practice with progressive involvement in professional affairs and hospital administration, culminating in his previous appointment as District Chief Executive Officer (CEO) of the Metro South Health Service District, which incorporated Princess Alexandra Hospital. 
David committed himself extensively to the activities of the Royal Australasian College of Surgeons, serving as national President and was awarded the College’s highest award (the Sir Hugh Devine Medal). 
In 2000, David was appointed Chairman of the Division of Surgery at PAH and he occupied this post until his appointment as PAH’s Clinical CEO in 2006, and ultimately Metro South’s District CEO in 2008.  David retired from this position in 2012, at which time he took up the position of Chairman of Diamantina Health Partners.  David joined TRI in 2016. 

Michelle Richards

Director - Building Operations

Michelle commenced as Director of Building Operations at TRI in 2016, after four years in WH&S and Facilities roles during the development of the TRI. Currently this role oversees Building Operations, Core facilities, Work Health & Safety, Scientific Services and Central Stores and Sterilisation functions. 
After completing a Bachelor of Science and Postgraduate diploma in Cardiovascular Medicine, Michelle worked for more than 10 years in Australia and the UK in medical research, gaining a broad foundation in areas including molecular biology, immunology, developmental biology and clinical trials.  Since then her focus has been on all areas of operational leadership at TRI, including space management, capacity planning, clinical trial facility development, and setting-up commercial and operational relationships with start-ups and incubator companies located on site.  


Louise Morland

Director - Communications and Marketing

Louise commenced at TRI in May 2014.  She is an experienced Marketing and Communications Director with a demonstrated history of working in the research, government and the commercial sectors. She has over 40 years’ experience in-house and in consultancies managing large teams (over 200 professionals) and budgets delivering communication, marketing and media functions. During this time, she has also led the communication responses for the Queensland Government to a number of Biosecurity crises and natural disasters.  Louise has a Bachelor of Business (Comms) from the Queensland University of Technology and a Bachelor of Arts (BA) from Macquarie University. 


professor graham Galloway

Director - Imaging Infrastructure

Graham is the Chief Executive Officer of the National Imaging Facility and is seconded by UQ to TRI as the Director- Imaging Infrastructure (0.5FTE). He is also Academic Lead for the Preclinical Imaging Core facility at TRI. 
Graham’s research is defined by finding innovative solutions to novel problems, of breaking new ground, of pushing the envelope of research using Magnetic Resonance. His publications include the first human liver and heart spectra, novel pulse sequences for volume selection and water suppression and the first 3D FSE echo experiments. His role in all projects is characterised by his multidisciplinary background, which ensures that he is able to draw together these apparently disparate threads. 


Kirsten Kiel-Chisholm

Director - Legal Services

Kirsten commenced at TRI in July 2009 and is an experienced General Counsel and Company Secretary.  As Director of Legal Services, Kirsten is responsible for managing the Institute’s legal requirements and providing legal advice to the Board and management across a range of areas. She also oversees human resources and compliance for the Institute.  
Kirsten previously worked as General Counsel and Company Secretary for the CRC for Sustainable Tourism.  Prior to that she was a corporate lawyer in private practice in both Australia and the United States and co-authored three publications on compliance with ASX and APRA corporate governance requirements.  She holds degrees in Law (First Class Hons) and International Business Relations as well as having a Graduate Diploma in Applied Corporate Governance.  She is In-House Counsel Certified by the Association of Corporate Counsel and a Fellow of the Governance Institute of Australia.   

Sue Davis

Director - Finance

Sue Davis joined TRI in July 2020 as Finance Director with strategic oversight of Finance, IT and Quality Management.  Prior to joining TRI Sue held senior finance and operational roles with TAFE Queensland, Bond University and Infinite Aged Care Group.